Auriemma Consulting Group Announces 30th Industry

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Auriemma Consulting Group Announces 30th Industry Roundtable in Firm's 30th Year

NEW YORK, Dec. 10, 2014 (GLOBE NEWSWIRE) -- Auriemma Consulting Group reached dual milestones in 2014, surpassing 30 Industry Roundtables as the consultancy marked its 30th anniversary. The announcement comes following the successful launch of three new groups this fall.

ACG has introduced an increasingly diverse set of resources to the financial services industry, expanding a platform that serves more than 100 participating firms in the US, UK, and Canada.

New offerings focus on critical compliance and customer experience areas — including vendor management and credit bureau disputes and reporting — and broaden the selection of fraud control services available to banks. The operation has also expanded into additional market segments: in October, ACG leveraged a core area of expertise to launch a Roundtable in the co-brand credit card space.

Recent additions join a range of established groups spanning credit, debit, auto finance, retail banking, and brokerage.

"Our ability to expand the practice into new vertical market sectors is evidence of the robustness of our model," said Jeff Tennenbaum, ACG's Director for Global Business Development, "and we continue to have ambitious plans for growth going forward."

Member organizations represent the majority of the top financial institutions, with more than 350 client memberships across all 30 groups.

Each Roundtable offers participating companies a suite of resources, including regular, peer-to-peer interaction, advisory services, and comprehensive benchmarking. With more than 350 studies performed annually, ACG is the preeminent source for benchmarking within the payments and lending industry.

Over the past three decades ACG's Industry Roundtables have become renowned within their respective disciplines, equipping members with a platform to compare practices, examine risk management techniques, and assess the performance of key business functions relative to the competitive landscape. Annual attrition has been below 4 percent historically.

"The Roundtables offer enormous return on investment potential for our partners," said Tom LaMagna, who leads the practice. "It's great to see that the Roundtables have become an organic part of our clients' business models."

About Auriemma Consulting Group

ACG is a boutique management consulting firm with specialized focus on the Payments and Lending space.  We deliver actionable solutions and insights that add value to our clients' business activities across a broad set of industry topics and disciplines.  Founded in 1984, ACG has grown from a one-man shop to a nearly 50-person firm with offices in New York and London.  Visit ACG's website at http://www.acg.net/ .  For more information about ACG's Industry Roundtables, please contact Tom LaMagna at 212-323-7000 or tom.lamagna@acg.net .



ACG ROUNDTABLE OFFERINGS:


INDIRECT AUTO FINANCE

  • Collections
  • Compliance
  • Customer Service
  • Dealer Finance
  • Originations
  • Canadian: Originations


CREDIT CARD

  • Accounting
  • Chargebacks
  • Chief Executive
  • CoBrand Partners
  • Collections
  • Compliance
  • Credit Bureau
  • Customer Service
  • Fraud
  • Recovery


MORTGAGE

  • Collections


BANKING

  • Customer Service
  • Debit Management
  • Fraud


BROKERAGE

  • Retirement Services


MULTI-VERTICAL

  • Dialer Strategy
  • Workforce Management


OTHER

  • Collection Agency Compliance


 
UNITED KINGDOM – CREDIT CARD

  • Accounting
  • Collections
  • Compliance
  • Customer Service
  • Fraud


UNITED KINGDOM – MORTGAGE

  • Collections
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading